Skip to content

PTSD: all studies

Page 133 of 211: studies 1,321 to 1,330 of 2,101, newest first. Back to the PTSD overview

Research

Psychometric properties of the 23-Item Clinician Administered Dissociative States Scale (CADSS) in a psychological trauma population.

Journal of Affective Disorders November 1, 2024 J Douglas Bremner, David Williamson, Viola Vaccarino 5 citations

Dissociative symptoms are both a pathological consequence of exposure to psychological trauma as well as a side effect of N-methyl-d-aspartate (NMDA) receptor antagonist medications; therefore, accurate and valid assessment of these symptoms is important. The psychometric properties of the 23-item Clinician Administered Dissociative States Scale (CADSS) have been characterized in the ketamine...

Psychoactive substances for the treatment of neuropsychiatric disorders.

Asian Journal of Psychiatry November 1, 2024 Zifan Zhen, Xueqiang Sun, Shiying Yuan et al. 8 citations

In the contemporary landscape of psychiatric medicine, critical advancements have been noted in the utilization of psychoactive substances such as hallucinogens, 3,4-methylenedioxymethamphetamine (MDMA), and ketamine for the treatment of severe mental health disorders. This review provides a detailed evaluation of these substances, focusing on their mechanisms of action and the profound...

DOI: 10.1016/j.ajp.2024.104193 (opens in new tab) Full text (opens in new tab) Ketamine MDMA Neuropsychiatric disorders Psychedelics hallucinogens +6

Expert recommendations for Germany’s integration of psychedelic-assisted therapy

BMC Medical Education October 24, 2024 Susanne Birnkammer, Olga Chernoloz, Sergio Pérez Rosal et al. 10 citations

As clinical trials for psychedelics move into phase III in the USA, Europe must address its lag in integrating professional education around psychedelic-assisted therapy (PAT) and supporting psychedelic drug research. This paper evaluates the necessary frameworks for implementing PAT in Germany, emphasizing the nation's potential leadership role within the European Union. With Australia having...

Rapid Effects of MDMA Administration on Self-Reported Personality Traits and Affect State: A Randomized, Placebo-Controlled Trial in Healthy Adults.

Journal of Psychoactive Drugs October 23, 2024 Jessica L Maples-Keller, Courtland S Hyatt, Nathaniel L Phillips et al. 2 citations

3,4-methylenedioxymethamphetamine (MDMA) assisted therapy has been shown to be a safe and effective treatment for PTSD and emerging research suggests a change in personality traits may be a factor in treatment response. Most prior research on MDMA and personality has focused on cross-sectional comparisons of MDMA users and non-users; as such, well-controlled research assessing personality and...

DOI: 10.1080/02791072.2024.2420044 (opens in new tab) Full text (opens in new tab) Affect Clinical trial Psychedelic research Clinical psychology +3

Psicoterapias assistidas por MDMA no tratamento do estresse pós-traumático em adultos: uma revisão integrativa

Revista Sociedade Científica October 22, 2024 Manuela Bahia Almeida da Franca, Sandra Regina Mota Ortiz

O Transtorno do Estresse Pós-Traumático (TEPT) é caracterizado por um conjunto de sinais e sintomas associados a um profundo sofrimento psicológico após a vivência ou testemunha de um episódio traumático. Apesar de muito prevalente na população, a abordagem atual do transtorno possui importantes limitações, o que afeta de maneira significativa a qualidade de vida dos afetados. Diante desse...

Uso de psicodélicos para tratamento de transtornos psiquiátricos: uma revisão integrativa

Bionorte October 22, 2024 Pedro Henrique Martins de Souza, Gilmerson Prates Souza 1 citation

Objetivo: verificar, por meio de estudos científicos, se a utilização de psicodélicos para o tratamento de transtornos psiquiátricos é uma estratégia eficiente. Materiais e Métodos: trata-se de uma revisão integrativa da literatura, cujo questionamento norteador para a investigação foi: “A utilização de psicodélicos, em doses apropriadas, é mais eficaz no tratamento de transtornos psiquiátricos...

Please show restraint: excessive focus on catastrophic events can lead to greater psychological trauma.

BMC Psychology October 18, 2024 Huaqiang Liu, Zhensong Lan, Qi Zhao et al.

This study explored the relationship between attention, negative emotions, empathy, mindfulness, and psychological trauma in catastrophic events to reduce psychological trauma in the public. A total of 526 adults in Guangxi Province, China, were investigated using self-rating scales for post-traumatic stress disorder, emotion, and empathy, as well as a five-factor self-rating mindfulness scale...

Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science

Translational Behavioral Medicine October 17, 2024 Danielle R Adams, Heidi L Allen, Ginger E. Nicol et al. 7 citations

Abstract Psychedelics (e.g., 3,4-Methylenedioxymethamphetamine [MDMA], lysergic acid diethylamide [LSD], psilocybin) are molecules that have the potential to produce rapid therapeutic effects when paired with psychotherapy. Randomized clinical trials of psychedelic-assisted psychotherapy (PAT) have shown promising results for post-traumatic stress disorder (PTSD), depression, and substance use...

Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy

Journal of Psychedelic Studies October 9, 2024 Jarrett Robert Rose 13 citations

Abstract Background and Aims This article examines the therapeutic potential of psilocybin in addressing Post-Traumatic Stress Disorder as the result of sexual abuse. PTSD is a prevalent form of mental distress resistant to most conventional treatment methods. Methods Through an in-depth analysis of the narratives of two individuals with longstanding, treatment-resistant mental health...

DOI: 10.1556/2054.2024.00363 (opens in new tab) Sexual abuse Psychotherapist Clinical psychology

Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine—A Systematic Review and Meta-Analysis

Psychoactives October 4, 2024 Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar 2 citations

Background: There is ongoing research into the potential use of psychedelics and 3,4-methylenedioxy-methamphetamine (MDMA) as alternatives to commonly used medications for treating major depressive and anxiety disorders. Aims: We aimed to assess the efficacy of psychedelics and MDMA in managing depressive and anxiety symptoms and evaluate their safety profiles. Methods: We searched five...

DOI: 10.3390/psychoactives3040029 (opens in new tab) Meta-analysis Antidepressant Methylenedioxy Methamphetamine +1